<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00199277</url>
  </required_header>
  <id_info>
    <org_study_id>DM01VEN/4/03</org_study_id>
    <nct_id>NCT00199277</nct_id>
  </id_info>
  <brief_title>Iron Therapy in Colo-Rectal Neoplasm and Iron Deficiency Anemia: Intravenous Iron Sucrose Versus Oral Ferrous Sulphate.</brief_title>
  <official_title>Randomized, Parallel Group, Clinical Trial Comparing Intravenous Iron Sucrose Versus Oral Ferrous Sulphate in the Treatment of Perioperative Iron Deficiency in Patients With Colo-Rectal Neoplasm and Iron Deficiency Anemia.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>J. Uriach and Company</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>J. Uriach and Company</source>
  <brief_summary>
    <textblock>
      The main objective of this study is to evaluate the efficacy of intravenous iron sucrose in
      increasing preoperative haemoglobin values in patients with colo-rectal neoplasm and iron
      deficiency anemia, compared to the standard treatment with oral iron. It will also determine
      whether intravenous iron sucrose administration improves outcomes such as postoperative
      haemoglobin values, serum ferritin values, transfusional needs, postoperative complications,
      or length of hospital stay.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Most patients with colorectal neoplasm have iron deficiency, which can be triggered in the
      pre-operative period by a decrease of iron intake and the bleeding in the site of neoplasm.

      In the postoperative period, iron deficiency can be aggravated by surgical bleeding.

      Iron plays a leading rol in haemoglobin production, cell mitosis and immune system. Animal
      experimentation has shown that induced iron deficiency and mild anemia lead to postoperative
      mortality and lactacidemia in a model of peritonitis.

      Moreover, anemia is the main risk factor to require intra and postoperative blood
      transfusions, and iron deficiency and anemia are associated to a larger number of
      postoperative complications (infections and longer hospital stay).

      Oral iron therapy is the standard treatment in patients with preoperative iron deficiency,
      but iron levels inside red cells may not reach normality in time before surgery, and it can
      not be resumed until the patient can start again oral feeding.

      In these patients, any increase in preoperative haemoglobin decreases the risk to need a
      blood transfusion during or after surgery.

      This trial will compare standard oral iron and intravenous iron.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Preoperative variations in hemoglobin.</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postoperative variations in hemoglobin.</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood transfusion needs (pre, intra and postoperative)</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative complications:</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>- Pulmonary thromboembolism</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>- Infections</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>- Reintervention</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>- Death</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of hospital stay</measure>
  </secondary_outcome>
  <enrollment>150</enrollment>
  <condition>Colorectal Neoplasm</condition>
  <condition>Iron Deficiency Anemia</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>i.v. iron sucrose</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Oral iron</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Non-recurrent colorectal neoplasm, surgically resectable

          -  Anemia

        Exclusion Criteria:

          -  Severe renal impairment

          -  High anesthetic risk
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pere Poch Martí, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Fundació Hospital-Asil de Granollers (Barcelona, Spain)</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital Universitari Germans Trias i Pujol</name>
      <address>
        <city>Badalona</city>
        <state>Barcelona</state>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Marta Piñol Pascual, MD</last_name>
    </contact>
    <investigator>
      <last_name>Marta Piñol Pascual, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Comarcal Sant Jaume de Calella.</name>
      <address>
        <city>Calella</city>
        <state>Barcelona</state>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Dolors Vela Payán, MD</last_name>
    </contact>
    <investigator>
      <last_name>Dolors Vela Payán, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fundació Hospital Asil de Granollers</name>
      <address>
        <city>Granollers</city>
        <state>Barcelona</state>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ramón López Ferré, MD</last_name>
    </contact>
    <investigator>
      <last_name>Ramón López Ferré, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Consorci Sanitari del Maresme</name>
      <address>
        <city>Mataró</city>
        <state>Barcelona</state>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Alba Bosch Llobet, MD</last_name>
    </contact>
    <investigator>
      <last_name>Alba Bosch Llobet, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Miguel Servet</name>
      <address>
        <city>Zaragoza</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>José Antonio García-Erce, MD</last_name>
    </contact>
    <investigator>
      <last_name>José Antonio García-Erce, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>September 2005</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 16, 2005</study_first_submitted>
  <study_first_submitted_qc>September 16, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 20, 2005</study_first_posted>
  <last_update_submitted>September 16, 2005</last_update_submitted>
  <last_update_submitted_qc>September 16, 2005</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 20, 2005</last_update_posted>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplasms</mesh_term>
    <mesh_term>Anemia</mesh_term>
    <mesh_term>Anemia, Iron-Deficiency</mesh_term>
    <mesh_term>Colorectal Neoplasms</mesh_term>
    <mesh_term>Deficiency Diseases</mesh_term>
    <mesh_term>Rectal Neoplasms</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Iron</mesh_term>
    <mesh_term>Ferric oxide, saccharated</mesh_term>
    <mesh_term>Ferric Compounds</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

